Hsin-Hung Chen

Prof. Hsin-Hung Chen


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 2019 in BMC Genetics
Verified
Journal Article
Open access
PDF file
KCKuang-Mao Chiang
Kuang-Mao Chiang
HCHeng-Cheng Chang
Heng-Cheng Chang
HYHsin-Chou Yang
Hsin-Chou Yang
CCChien-Hsiun Chen
Chien-Hsiun Chen
HCHsin-Hung Chen
Hsin-Hung Chen
WPWen-Harn Pan
Wen-Harn Pan
Background: As obesity is becoming pandemic, morbid obesity (MO), an extreme type of obesity, is an emerging issue worldwide. It is imperative to understand the factors responsible for huge weight gain in certain populations in the modern society. Very few genome-wide association studies (GWAS) have been conducted on MO patients. This study is the first MO-GWAS study in the Han-Chinese population in Asia. Methods: We conducted a two-stage GWAS with 1110 MO bariatric patients (body mass index [BMI] ≥ 35 kg/m2) from Min-Sheng General Hospital, Taiwan. The first stage involved 575 patients, and 1729 sex- and age-matched controls from the Taiwan Han Chinese Cell and Genome Bank. In the second stage, another 535 patients from the same hospital were genotyped for 52 single nucleotide polymorphisms (SNPs) discovered in the first stage, and 9145 matched controls from Taiwan Biobank were matched for confirmation analysis. Results: The results of the joint analysis for the second stage revealed six top ranking SNPs, including rs8050136 (p-value = 7.80 × 10− 10), rs9939609 (p-value = 1.32 × 10− 9), rs1421085 (p-value = 1.54 × 10− 8), rs9941349 (p-value = 9.05 × 10− 8), rs1121980 (p-value = 7.27 × 10− 7), and rs9937354 (p-value = 6.65 × 10− 7), which were all located in FTO gene. Significant associations were also observed between MO and RBFOX1, RP11-638 L3.1, TMTC1, CBLN4, CSMD3, and ERBB4, respectively, using the Bonferroni correction criteria for 52 SNPs (p < 9.6 × 10− 4). Conclusion: The most significantly associated locus of MO in the Han-Chinese population was the well-known FTO gene. These SNPs located in intron 1, may include the leptin receptor modulator. Other significant loci, showing weak associations with MO, also suggested the potential mechanism underlying the disorders with eating behaviors or brain/neural development.

13 December 2012 in Genetic Testing and Molecular Biomarkers
Verified
Journal Article
Closed access
MLMing-Fen Lee
Ming-Fen Lee
Tsan-Hon LiouTsan-Hon Liou
Tsan-Hon Liou
WWWeu Wang
Weu Wang
WPWen-Harn Pan
Wen-Harn Pan
WLWei-Jei Lee
Wei-Jei Lee
HCHsin-Hung Chen
Hsin-Hung Chen
Hyperuricemia is closely associated with obesity and metabolic abnormalities, which is also an independent risk factor for cardiovascular diseases. The PPARγ gene, which is linked to obesity and metabolic abnormalities in Han Chinese, might be considered a top candidate gene that is involved in hyperuricemia. This study recruited 457 participants, aged 20-40 years old, to investigate the associations of the PPARγ gene and metabolic parameters with hyperuricemia. Three tag-single nucleotide polymorphisms, rs2292101, rs4684846, and rs1822825, of the PPARγ gene were selected to explore their association with hyperuricemia. Risk genotypes on rs1822825 of the PPARγ gene exhibited statistical significance with hyperuricemia (odds ratio: 1.9; 95% confidence interval: 1.05-3.57). Although gender, body mass index (BMI), serum total cholesterol concentration, or protein intake per day were statistically associated with hyperuricemia, the combination of BMI, gender, and rs1822825, rather than that of age, serum lipid profile, blood pressure, and protein intake per day, satisfied the predictability for hyperuricemia (sensitivity: 69.3%; specificity: 83.7%) in Taiwan-born obese Han Chinese. BMI, gender, and the rs1822825 polymorphism in the PPARγ gene appeared good biomarkers in hyperuricemia; therefore, these powerful indicators may be included in the prediction of hyperuricemia to increase the accuracy of the analysis.

2 February 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
JGJiun-Yu Guo
Jiun-Yu Guo
HCHsin-Hung Chen
Hsin-Hung Chen
WLWei Jei Lee
Wei Jei Lee
SCShu-Chun Chen
Shu-Chun Chen
SLShou-Dong Lee
Shou-Dong Lee
CCChih-Yen Chen
Chih-Yen Chen
Background: Gastric bypass (GB) is an effective treatment for those who are morbidly obese with coexisting type 2 diabetes mellitus (T2DM) or non-alcoholic fatty liver disease (NAFLD). Fibroblast growth factors (FGFs) are involved in the regulation of energy metabolism. Methods: We investigated the roles of FGF 19, FGF 21, and total bile acid among those with morbidly obese and T2DM undergoing GB. A total of 35 patients were enrolled. Plasma FGF 19, FGF 21, and total bile acid levels were measured before surgery (M0), 3 months (M3), and 12 months (M12) after surgery, while the hepatic steatosis index (HSI) was calculated before and after surgery. Results: Obese patients with T2DM after GB presented with increased serum FGF 19 levels (p = 0.024) and decreased total bile acid (p = 0.01) and FGF 21 levels (p = 0.005). DM complete remitters had a higher FGF 19 level at M3 (p = 0.004) compared with DM non-complete remitters. Fatty liver improvers tended to have lower FGF 21 (p = 0.05) compared with non-improvers at M12. Conclusion: Changes in FGF 19 and FGF 21 play differential roles in DM remission and NAFLD improvement for patients after GB. Early increases in serum FGF 19 levels may predict complete remission of T2DM, while a decline in serum FGF 21 levels may reflect the improvement of NAFLD after GB.

1 January 2014 in Surgery for Obesity and Related Diseases
Verified
Journal Article
Closed access
WWWeu Wang
Weu Wang
Tsan-Hon LiouTsan-Hon Liou
Tsan-Hon Liou
WLWei-Jei Lee
Wei-Jei Lee
CHChung-Tan Hsu
Chung-Tan Hsu
MLMing-Fen Lee
Ming-Fen Lee
HCHsin-Hung Chen
Hsin-Hung Chen

23 July 2022 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
YHYu-Min Huang
Yu-Min Huang
WWWeu Wang
Weu Wang
SWShu-Chen Wei
Shu-Chen Wei
PLPei-Fen Lee
Pei-Fen Lee
YHYi-Chiang Hsu
Yi-Chiang Hsu
HCHsin-Hung Chen
Hsin-Hung Chen